Showing results (1-10 of 202) with videos related to
Sort By:
Pageof 21
Current Treatment Options in Gastroenterology|October 27, 2018
Potent Acid Suppression with PPIs and P-CABs: What's New?Richard H Hunt, Carmelo ScarpignatoGastroenterology Clinics of North America|October 19, 2010
Nonsteroidal antiinflammatory drug-related injury to the gastrointestinal tract: clinical picture, pathogenesis, and preventionCarmelo Scarpignato, Richard H HuntCurrent Gastroenterology Reports|August 15, 2024
Potassium-competitive Acid Blockers: Current Clinical Use and Future DevelopmentsCarmelo Scarpignato, Richard H HuntCurrent Opinion in Pharmacology|October 9, 2008
Proton pump inhibitors: the beginning of the end or the end of the beginning?Carmelo Scarpignato, Richard H HuntCurrent Opinion in Gastroenterology|May 3, 2019
The potential role of potassium-competitive acid blockers in the treatment of gastroesophageal reflux diseaseCarmelo Scarpignato, Richard H HuntClinical and Translational Gastroenterology|October 30, 2015
Potassium-Competitive Acid Blockers (P-CABs): Are They Finally Ready for Prime Time in Acid-Related Disease?Richard H Hunt, Carmelo ScarpignatoAnnals of Medicine|May 12, 2009
Myths and facts in the use of anti-inflammatory drugsRichard H Hunt, Angel Lanas, Dirk O Stichtenoth, et al.Annals of the New York Academy of Sciences|August 22, 2020
Gastrointestinal pharmacology: practical tips for the esophagologistCarmelo Scarpignato, Joshua A Sloan, David H Wang, et al.BMC Medicine|April 11, 2015
Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis--an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risksCarmelo Scarpignato, Angel Lanas, Corrado Blandizzi, et al.Neurogastroenterology and Motility|July 13, 2012
Poor effectiveness of proton pump inhibitors in non-erosive reflux disease: the truth in the end!Carmelo ScarpignatoPageof 21